CD4 and melanoma: Recent studies in melanoma have revealed that neoantigen-specific CD8+ and CD4+ T cells—including cytotoxic and regulatory subsets—can be clonally expanded in response to class I- and class II-restricted neoantigens, contributing to both immune activation and localized immunosuppression (23, 24).